However, most of the previously mentioned studies focused on high plasma Fib levels or low serum Alb levels at the time of pretreatment, with dreadful prognosis in patients with rectal cancer, without taking into consideration of changes during the preoperative treatment. This evidence concerns the gene FBL and rectal cancer.